Insider Trading March 12, 2026 11:41 PM

Arlo CEO Disposes $2.1M in Shares After PSU Conversion; Company Posts Strong Q4 Results

Insider sale follows exercise of performance stock units as Arlo reports Q4 2025 earnings beat and board approves up to $50M buyback through 2027

By Maya Rios ARLO

Arlo Technologies Chief Executive Matthew Blake Mcrae sold 153,433 shares on March 12, 2026, generating roughly $2.1 million, after converting performance stock units into common shares two days earlier. The company posted better-than-expected fourth-quarter results and its board authorized a $50 million open-market repurchase program running through Dec. 31, 2027. InvestingPro flags the stock as appearing overvalued even as analysts’ price targets range from $18 to $26.

Arlo CEO Disposes $2.1M in Shares After PSU Conversion; Company Posts Strong Q4 Results
ARLO

Key Points

  • Arlo CEO Matthew Blake Mcrae sold 153,433 shares on March 12, 2026, for roughly $2.1 million at a weighted average price of $13.7752.
  • Mcrae exercised 288,824 performance stock units on March 10, 2026, which converted to common stock at a $0 price, bringing his direct ownership to 1,168,866 shares.
  • Arlo beat Q4 2025 estimates with EPS of $0.22 and revenue of $141.3 million, and its board authorized up to $50 million in open-market share repurchases through Dec. 31, 2027.

Arlo Technologies reported a notable insider transaction this month when Chief Executive Officer Matthew Blake Mcrae sold 153,433 shares of common stock on March 12, 2026, for about $2.1 million, according to a Form 4 filing with the Securities and Exchange Commission.

The shares were sold at a weighted average price of $13.7752, with trade prices recorded between $13.605 and $13.7759. As of the latest quote included in the filing, Arlo's shares trade at $13.51 and the company carries a market capitalization of $1.44 billion.

The filing also shows that Mcrae acquired 288,824 shares on March 10, 2026, through the exercise of performance stock units (PSUs). Those PSUs converted into common stock at a price of $0, increasing his direct holdings.

After the March transactions, Mcrae's direct ownership in Arlo Technologies stands at 1,168,866 shares.


Recent financial performance and corporate actions

Separately from the insider activity, Arlo released its fourth-quarter 2025 financial results, which exceeded analyst expectations. The company reported earnings per share of $0.22 versus a consensus forecast of $0.16, a 37.5% surprise relative to the estimate. Revenue for the quarter reached $141.3 million, topping the anticipated $133.95 million — a 5.49% surprise.

In a further capital-allocation move, Arlo's board has authorized a share repurchase program of up to $50 million. The repurchase plan will be executed through open market purchases and is authorized to run through December 31, 2027.


Valuation and analyst context

Investment research noted in the filing highlights a mixed picture on valuation. According to InvestingPro analysis cited in the disclosure, the stock appears overvalued at current levels. At the same time, analyst price targets that follow the company span from $18 to $26. The company is described as having a "GOOD" financial health rating in that same analysis.

Taken together, the insider transactions, quarterly results beat, and the board-authorized repurchase program provide a collection of recent developments that investors and market participants will incorporate as they assess Arlo's outlook and valuation.

Risks

  • Valuation uncertainty: InvestingPro analysis indicates the stock appears overvalued at current levels, which may contrast with analyst price targets ranging from $18 to $26. (Impacted sectors: equity markets, technology-related equities).
  • Execution uncertainty for the repurchase program: while the board approved up to $50 million in open-market buybacks through December 31, 2027, the timing and pace of purchases are not specified in the filing. (Impacted sectors: capital markets, corporate finance).

More from Insider Trading

Spero Therapeutics Executive Executes Automatic Stock Sale Amid Strong Financial Turnaround May 6, 2026 Natera Executive Chairman Executes $1.64 Million in Stock Dispositions May 6, 2026 Insider Activity Detected at Rallybio Corp Following Substantial Share Acquisitions May 6, 2026 A10 Networks Director Eric Singer Executes Stock Sale Amidst Recent Earnings Strength May 6, 2026 Delek US Holdings Director Ezra Uzi Yemin Executes $1.6 Million Stock Sale May 6, 2026